Rifampicin-induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: A case report

Respirol Case Rep. 2023 Jul 17;11(8):e01190. doi: 10.1002/rcr2.1190. eCollection 2023 Aug.

Abstract

Drug-induced tubulointerstitial nephritis is an uncommon complication in patients on anti-tuberculosis therapy that can lead to permanent kidney damage. Rifampicin is the most offending drug. We report a case of a 41-years old man being treated for pulmonary tuberculosis and presenting with tubulointerstitial nephritis associated with rifampicin. We focus on diagnosis features and therapeutic challenges.

Keywords: acute kidney injury; acute renal failure; acute tubulointerstitial nephritis; rifampicin; tuberculosis.

Publication types

  • Case Reports